Fairfax employs a clever M&A strategy called the "cannibal buy-up." When an asset is too large to acquire outright, they partner with another firm. Later, when financially stronger, they use their capital to buy out the partner's stake, allowing them to gain 100% control of a valuable asset over time.

Bond insurer Assured Guaranty isn't in a high-growth industry, but its management consistently buys back 12-13% of its shares annually at a large discount to book value. This superior capital allocation has driven extraordinary growth in book value per share.

While a soft market slows premium growth, it also reduces the need for capital to back new business. This frees up significant cash flow for Fairfax to execute accretive buybacks and other capital returns, especially when the stock trades at a discount to its intrinsic value.

To maintain pricing discipline, Fairfax has a strict M&A rule: it never participates in auctions or bidding wars. Once an offer is made, it's final. This strategy prevents them from overpaying and ensures they only acquire companies at prices that offer attractive future returns.

The company's Total Return Swaps (TRS) are not just a speculative bet but a strategic tool. They function as a deferred buyback, allowing Fairfax to lock in a price while using the capital elsewhere until they formally close the swap and take delivery of the shares.

Companies termed "share cannibals" aggressively repurchase their own shares, especially when undervalued. This capital allocation strategy is often superior to dividends because it transfers value from sellers to long-term shareholders and acts as a high-return, low-risk investment in the company's own business.

Fairfax executed a brilliant capital allocation move by selling a 10% stake in its subsidiary, Odyssey, to pension funds for 1.7 times its book value. They then used the billion-dollar proceeds to buy back their own undervalued parent company stock, which was trading at a discount of 0.9x book value.

When a company's stock trades at a significant discount to tangible assets, the market signals that every new dollar invested is immediately devalued. The correct capital allocation is returning capital to shareholders via buybacks or dividends, not pursuing growth projects that the market refuses to credit.

Fairfax maintains a balance sheet with roughly $75 billion in investments against $25 billion in equity. This leverage is primarily funded by low-cost insurance float and some debt, creating a powerful engine for returns that the speakers argue is a "better mousetrap than Berkshire."